At a glance
ClinicalIndex Comparison RecordN/ACompleted· 36 enrolled
Drug / intervention
SkinStylus Sterilock Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Clinical Efficacy And Safety Of SkinStylus Microneedling System for Ventral Torso Hypertrophic Scars: Clinical Results With 30 Patients
In Brief
A clinical study evaluating SkinStylus Sterilock System for Cicatrix, Hypertrophic. Completed, enrolled 36 participants across 1 site.
Detailed Summary
The purpose of the trial is to provide objective evidence the SkinStylus may be used safely and effectively for the treatment of ventral torso hypertrophic scars.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCicatrix, Hypertrophic
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
Enrollment StartNov 2017
First PostedDec 2017
Primary CompletionNov 2018
Study CompletionDec 2018
TodayJul 2026
First PostedDec 8, 2017
Enrollment StartNov 15, 2017
Primary CompletionNov 1, 2018
Study CompletionDec 1, 2018
TodayJul 2, 2026
Enrollment to primary: 12 monthsPosted 8.6 years ago
Interventions
SkinStylus Sterilock Systemdevice
Microneedling device will be used to treat ventral hypertrophic scars.